A Combinatorial Strategy for Targeting


Journal

Clinical cancer research : an official journal of the American Association for Cancer Research
ISSN: 1557-3265
Titre abrégé: Clin Cancer Res
Pays: United States
ID NLM: 9502500

Informations de publication

Date de publication:
15 04 2020
Historique:
received: 15 05 2019
revised: 03 09 2019
accepted: 10 01 2020
pubmed: 16 1 2020
medline: 28 1 2021
entrez: 16 1 2020
Statut: ppublish

Résumé

Most aggressive thyroid cancers are commonly associated with a The combined drug activity was analyzed to predict any synergistic effect using high-throughput screening (HTS) of active drugs. We performed follow-up The MTKI ponatinib and the BRAF inhibitor PLX4720 showed synergistic activity by HTS. This combination significantly inhibited proliferation, colony formation, invasion, and migration in Combination treatment with ponatinib and PLX4720 exhibited significant synergistic anticancer activity in preclinical models of

Identifiants

pubmed: 31937621
pii: 1078-0432.CCR-19-1606
doi: 10.1158/1078-0432.CCR-19-1606
pmc: PMC8606228
mid: NIHMS1550098
doi:

Substances chimiques

Imidazoles 0
Indoles 0
PLX 4720 0
Pyridazines 0
Sulfonamides 0
ponatinib 4340891KFS
Protein-Tyrosine Kinases EC 2.7.10.1
BRAF protein, human EC 2.7.11.1
Proto-Oncogene Proteins B-raf EC 2.7.11.1

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2022-2036

Subventions

Organisme : Intramural NIH HHS
ID : ZIA BC011286
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA TR000108
Pays : United States

Informations de copyright

©2020 American Association for Cancer Research.

Références

Mol Cancer Res. 2014 Jul;12(7):979-86
pubmed: 24770869
J Natl Compr Canc Netw. 2016 Mar;14(3):249-54
pubmed: 26957611
J Clin Invest. 2016 Mar 1;126(3):1052-66
pubmed: 26878173
Oncotarget. 2015 Apr 20;6(11):9073-85
pubmed: 25940539
Clin Cancer Res. 2019 May 15;25(10):3141-3151
pubmed: 30737244
Ann Transl Med. 2017 Oct;5(19):387
pubmed: 29114545
Oncogene. 2017 Jun 1;36(22):3178-3192
pubmed: 28092672
J Clin Endocrinol Metab. 2012 Mar;97(3):E319-28
pubmed: 22170715
Endocr Relat Cancer. 2015 Jun;22(3):319-29
pubmed: 25972243
Head Neck. 2012 Feb;34(2):230-7
pubmed: 21500309
Surgery. 2016 Jan;159(1):152-62
pubmed: 26456124
Ann Oncol. 2014 May;25(5):959-67
pubmed: 24504448
Hum Mol Genet. 2015 Apr 15;24(8):2318-29
pubmed: 25576899
Nature. 2010 Dec 16;468(7326):973-7
pubmed: 21107323
Oncotarget. 2017 Jan 24;8(4):5874-5884
pubmed: 27564113
Thyroid. 2019 Jan;29(1):79-92
pubmed: 30398411
Nature. 2017 Oct 5;550(7674):133-136
pubmed: 28953887
Clin Cancer Res. 2015 Sep 15;21(18):4123-32
pubmed: 25944801
J Clin Endocrinol Metab. 2017 Feb 1;102(2):634-643
pubmed: 27754804
Pharmacol Rev. 1989 Jun;41(2):93-141
pubmed: 2692037
Oncologist. 2011;16(3):296-309
pubmed: 21355020
Comput Struct Biotechnol J. 2015 Sep 25;13:504-13
pubmed: 26949479
N Engl J Med. 2015 Aug 20;373(8):726-36
pubmed: 26287849
Protein Cell. 2019 Mar;10(3):161-177
pubmed: 29667003
Cancer Discov. 2013 May;3(5):520-33
pubmed: 23365119
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Cancer Res. 2017 Jan 15;77(2):459-469
pubmed: 27879272
F1000Res. 2018 Jan 18;7:
pubmed: 31583077
NPJ Precis Oncol. 2017;1:
pubmed: 29152593
Cancer Discov. 2014 Jan;4(1):61-8
pubmed: 24265154
Oncotarget. 2016 Mar 29;7(13):16517-28
pubmed: 26934320
Cancer Res. 2010 Jan 15;70(2):440-6
pubmed: 20068163
J Clin Oncol. 2018 Jan 1;36(1):7-13
pubmed: 29072975
Eur J Cancer. 2016 Jul;62:76-85
pubmed: 27232329
Cancer. 2015 Apr 1;121(7):1017-24
pubmed: 25425528
Cancer Cell. 2007 May;11(5):447-60
pubmed: 17482134
Pigment Cell Melanoma Res. 2018 May;31(3):432-436
pubmed: 29171936
Cancer Cell. 2015 Feb 9;27(2):240-56
pubmed: 25600339
Oncotarget. 2015 Jul 20;6(20):18038-49
pubmed: 25945839
N Engl J Med. 2014 Nov 13;371(20):1877-88
pubmed: 25265492
PLoS One. 2016 Oct 19;11(10):e0164840
pubmed: 27760217

Auteurs

Chandrayee Ghosh (C)

Department of Surgery, Stanford University, Stanford, California.

Suresh Kumar (S)

Laboratory of Genetics and Genomics, National Institute of Aging, Bethesda, Maryland.

Yevgeniya Kushchayeva (Y)

National Institute of Digestive and Kidney Diseases, NIH, Bethesda, Maryland.

Kelli Gaskins (K)

NCI, NIH, Bethesda, Maryland.

Myriem Boufraqech (M)

NCI, NIH, Bethesda, Maryland.

Darmood Wei (D)

NCI, NIH, Bethesda, Maryland.

Sudheer Kumar Gara (SK)

NCI, NIH, Bethesda, Maryland.

Lisa Zhang (L)

National Institute of Child Health and Development, NIH, Bethesda, Maryland.

Ya-Qin Zhang (YQ)

National Center for Advancing Translational Sciences, NIH, Bethesda, Maryland.

Min Shen (M)

National Center for Advancing Translational Sciences, NIH, Bethesda, Maryland.

Sanjit Mukherjee (S)

Genetics Branch, NCI, Bethesda, Maryland.

Electron Kebebew (E)

Department of Surgery, Stanford University, Stanford, California. kebebew@stanford.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH